Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology

Powder Technology

Volumn 189, Issue 1, 2009, Pages 97-102

  Varshosaz, J ^a   Hassanzadeh, F ^a   Mahmoudzadeh, M ^a   Sadeghi, A ^a  

^a Isfahan Faculty of Pharmacy   (Iran)

Author keywords

Cefuroxime axetil; Dissolution; Nanoparticles; Supercritical fluid technology

Indexed keywords

BIOCHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; EFFLUENT TREATMENT; FEEDBACK AMPLIFIERS; FLUIDS; INDUSTRIAL WASTE TREATMENT; LASER INTERFEROMETRY; NANOPARTICLES; NOZZLES; PARTICLE SIZE; SUPERCRITICAL FLUIDS; TECHNOLOGY; WATER ABSORPTION; X RAY ANALYSIS; ZETA POTENTIAL;

AVERAGE PARTICLE SIZES; BIO AVAILABILITIES; CEFUROXIME AXETIL; COMPLETE DISSOLUTIONS; DISSOLUTION RATES; EFFECTIVE ABSORPTIONS; EXTRACTION COLUMNS; EXTRACTION TEMPERATURES; FULL FACTORIAL DESIGNS; GASTROINTESTINAL TRACTS; NOZZLE TEMPERATURES; PROCESS PARAMETERS; RAPID EXPANSION OF SUPERCRITICAL SOLUTIONS; RAPID EXPANSIONS; SUPERCRITICAL FLUID TECHNOLOGY; THREE LEVELS; X-RAY DIFFRACTIONS;

DISSOLUTION;

CEFUROXIME AXETIL; NANOPARTICLE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; PARTICLE SIZE; SUPERCRITICAL FLUID; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 57649201936     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2008.06.009     Document Type: Article

References (34)

1. McEvoy G.K. Cephalosporins: cefuroxime sodium and cefuroxime axetil. AHFS Drug Information (2003), American Society of Hospital Pharmacists Inc, Bethesda, MD 223-231
2. McEvoy G.K. Cephalosporins: cefuroxime sodium and cefuroxime axetil. AHFS Drug Information (1994), American Society of Hospital Pharmacists Inc, Bethesda, MD 152-159
3. Oszczapowicz I., Malafiej E., Szelachowska M., Horoszewicz-Malafiej A., Kuklewicz C., Sieranska E., Denys A., and Niedworok J. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime. Acta Polon. Pharm. Drug Res. 52 (1995) 397-401
4. Mosharrafand M., and Nyström C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int. J. Pharm. 122 (1995) 35-47
5. Müller R.H., Jacobs C., and Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47 (2001) 3-19
6. M. Gibson, Pharmaceutical Preformulation and Formulation-A Practical Guide from Candidate Drug Selection to Commercial Dosage Form. HIS Health Group, Englewood (2001).
7. Kim S.T., Kwon J.H., Lee J.J., and Kim C.W. Microcrystallization of indomethacin using a pH-shift method. Int. J. Pharm. 263 1-2 (2003) 141-150
8. Chaumeil J.C. Micronization: a method of improving the bioavailability of poorly soluble drugs. Meth. Find. Exp. Clin. Pharmacol. 20 (1998) 211-215
9. Parrott E.L. Comminution. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology vol. 3 (1990), Marcel Decker, New York 101-121
10. Kaneniwa N., and Ikekawa A. Influence of ball-milling atmosphere on decrease of molecular weight of polyvinylpyrrolidone powders. Chem. Pharm. Bull. 20 (1972) 1536-1543
11. Waltersson J.O., and Lundgren P. The effect of mechanical comminution on drug stability. Acta Pharm. Suec. 22 (1985) 291-300
12. Vidgrén M.T., Vidgrén P.A., and Paronen T.P. Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate. Int. J. Pharm. 35 (1987) 139-144
13. Chawla A., Taylor K.M.G., Newton J.M., and Johnson M.R.C. Production of spray-dried salbutamol sulphate for use in dry powder aerosol formulations. Int. J. Pharm. 108 (1994) 233-240
14. Steckel H., Rasenack N., and Müller B.W. In-situ-micronization of disodium cromoglycate for pulmonary delivery. Eur. J. Pharm. Biopharm. 55 2 (2003) 173-180
15. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18 2 (2003) 113-120
16. Krause K.P., and Müller R.H. Production and characterisation of highly concentrated nanosuspensions by high pressure homogenization. Int. J. Pharm. 214 (2001) 21-24
17. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids 20 (2001) 179-219
18. Perrut M. Supercritical fluids applications in the pharmaceutical industry. STP Pharm. Sci. 13 (2003) 83-91
19. Perrut M., and Clavier J.Y. Supercritical fluid formulation: process choice and scale-up. Ind. Eng. Chem. Res. 42 (2003) 6375-6383
20. Jung J., Leboeuf F., and Perrut M. Supercritical fluid micro-encapsulation. In: Besnard M., and Cansell F. (Eds). Proceedings of the Eighth Meeting on Supercritical Fluids, Bordeaux, France (2002) 805-812
21. I. Kikic, M. Moneghini, B. Perissutti, D. Voinovich, Improvement of carbamazepine dissolution characteristics using supercritical carbon dioxide. In: M. Perrut, E. Reverchon, Editors, Proceedings of the Seventh Meeting on Supercritical Fluids, Tome 1 (2000), pp. 95-100.
22. Z. Knez, Micronization of pharmaceuticals using supercritical fluids. In: M. Perrut, E. Reverchon, Editors, Proceedings of the Seventh Meeting on Supercritical Fluids, Tome 1 (2000), pp. 1-26.
23. Jo G.H., Yu J.H., Yun J.H., Hwang S.J., and Woo J.S. Preparation of amorphous form of cefuroxime axetil using supercritical fluid processing. Proceedings of the C.R.S. 29th Annual Meeting (2002)
24. Nam K.W., Lee S., Hwang S.J., and Woo J.S. Enhancing water-solubility of poorly soluble drug itraconazole with water-soluble polymer using supercritical fluid processing. Proceedings of the C.R.S. 29th Annual Meeting (2002)
25. H.A. Crisp, J.C. Clayton, L.G. Elliott and E.M. Wilson, Process for preparing cefuroxime axetil, US Patent 5,013,833 (1991).
26. Jun S.W., Kim M.S., Jo G.H., Lee S., Woo J.S., Park J.S., and Hwang S.J. Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids. J. Pharm. Pharmacol. 57 (2005) 1529-1537
27. Zhang J.Y., Shen Z.G., Zhong J., Hu T.T., Chen J.F., Ma Z.Q., and Yun J. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int. J. Pharm. 323 1-2 (2006) 153-160
28. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly soluble active ingredients by supercritical fluid processes Part II: Preparation of composite particles. Int. J. Pharm. 288 1 (2005) 11-16
29. Pasquali I., Bettini R., and Giordano F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur. J. Pharm. Sci. 27 4 (2006) 299-310
30. Banakar U.V. Pharmaceutical Dissolution Testing. 1st ed. (1992), Marcel Dekker Inc, New York
31. Shaub G.R., Brennecke J.F., and McCready M.J. Radial model for particle formation from the rapid expansion of supercritical solutions. J. Supercrit. Fluids 8 4 (1995) 318-328
32. 2 and its micronization by RESS. J. Supercrit. Fluids 6 4 (1993) 241-248
33. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: Part I: Micronization of neat particles. Int. J. Pharm. 288 1 (2005) 3-10
34. Chiou A.H.J., Yeh M.K., Chen C.Y., and Wang D.P. Micronization of meloxicam using a supercritical fluids process. J. Supercrit. Fluids 42 1 (2007) 120-128